Javascript must be enabled to continue!
Abstract 445: Increasing Macrophage Survival Delays Progression of Advanced Atherosclerotic Lesions Through Macrophage-Derived ApoE
View through CrossRef
Introduction/Hypothesis:
We previously demonstrated that increasing macrophage survival delayed atherosclerotic plaque progression towards advanced stages. However, whether cell death-protected macrophages would still be efficient to hinder the progression and favor the resolution of already advanced atherosclerotic lesions, and thus prove therapeutic potential, remains unknown.
Methods:
We used a transgenic mouse model in which macrophage lifespan is enhanced through specific overexpression of the antiapoptotic gene hBcl-2 under the control of the macrophage specific CD68 promoter (Mø-hBcl2).
Apoe
-/-
or
Ldlr
-/-
recipient mice with advanced atherosclerotic lesions were irradiated and then transplanted with bone marrow cells isolated from
Apo
e
-/-
Mø-h
Bcl2
or
Apo
e
+/+
Mø-hBcl2 mice respectively and their appropriate controls.
Results:
Both
Apoe
-/-
Mø-h
Bcl2
→
Apoe
-/-
and
Apoe
+/+
Mø-h
Bcl2
→
Ldl
r
-/-
mice presented a significant decrease in lesional apoptotic cells content (-30%, P<0.05) as compared to their respective controls. Additionally, hBcl2 expression in macrophages was associated with a larger pool of tissue macrophages in vivo, including Küppfer cells in the liver, in both Apoe
-/-
(+40% P<0.05) and
Ldlr
-/-
(+36% P<0.05) recipients. By contrast, only
Ldlr
-/-
recipient mice showed reduction of lesional necrotic areas (-37%, P<0.05), plasma cholesterol levels (-15%, P<0.05) and atherosclerotic lesions (-30%, P<0.05). As those reductions were not significant in the context of ApoE deficiency, these findings supported that Mø-derived ApoE was key in regulating plasma cholesterol levels, lesional necrosis and advanced plaque progression in the context of increased macrophage pool. Indeed, increased liver Küpffer cells content in the liver of
Ldlr
-/-
recipient mice was associated with elevated ApoE mRNA levels (+30%, P<0.05), which is likely to promote reverse cholesterol transport.
Conclusions:
Collectively, these data suggest that macrophage survival hindered advanced lesion progression. One potential mechanistic explanation lied to the increased Küpffer cells content, which could modulate directly or indirectly cholesterol homeostasis.
Ovid Technologies (Wolters Kluwer Health)
Title: Abstract 445: Increasing Macrophage Survival Delays Progression of Advanced Atherosclerotic Lesions Through Macrophage-Derived ApoE
Description:
Introduction/Hypothesis:
We previously demonstrated that increasing macrophage survival delayed atherosclerotic plaque progression towards advanced stages.
However, whether cell death-protected macrophages would still be efficient to hinder the progression and favor the resolution of already advanced atherosclerotic lesions, and thus prove therapeutic potential, remains unknown.
Methods:
We used a transgenic mouse model in which macrophage lifespan is enhanced through specific overexpression of the antiapoptotic gene hBcl-2 under the control of the macrophage specific CD68 promoter (Mø-hBcl2).
Apoe
-/-
or
Ldlr
-/-
recipient mice with advanced atherosclerotic lesions were irradiated and then transplanted with bone marrow cells isolated from
Apo
e
-/-
Mø-h
Bcl2
or
Apo
e
+/+
Mø-hBcl2 mice respectively and their appropriate controls.
Results:
Both
Apoe
-/-
Mø-h
Bcl2
→
Apoe
-/-
and
Apoe
+/+
Mø-h
Bcl2
→
Ldl
r
-/-
mice presented a significant decrease in lesional apoptotic cells content (-30%, P<0.
05) as compared to their respective controls.
Additionally, hBcl2 expression in macrophages was associated with a larger pool of tissue macrophages in vivo, including Küppfer cells in the liver, in both Apoe
-/-
(+40% P<0.
05) and
Ldlr
-/-
(+36% P<0.
05) recipients.
By contrast, only
Ldlr
-/-
recipient mice showed reduction of lesional necrotic areas (-37%, P<0.
05), plasma cholesterol levels (-15%, P<0.
05) and atherosclerotic lesions (-30%, P<0.
05).
As those reductions were not significant in the context of ApoE deficiency, these findings supported that Mø-derived ApoE was key in regulating plasma cholesterol levels, lesional necrosis and advanced plaque progression in the context of increased macrophage pool.
Indeed, increased liver Küpffer cells content in the liver of
Ldlr
-/-
recipient mice was associated with elevated ApoE mRNA levels (+30%, P<0.
05), which is likely to promote reverse cholesterol transport.
Conclusions:
Collectively, these data suggest that macrophage survival hindered advanced lesion progression.
One potential mechanistic explanation lied to the increased Küpffer cells content, which could modulate directly or indirectly cholesterol homeostasis.
Related Results
Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
Lipoprotein glomerulopathy induced by ApoE Kyoto mutation in ApoE-deficient mice
Abstract
Background: Lipoprotein glomerulopathy (LPG) is a rare autosomal dominant kidney disease that is most commonly caused by mutations in ApoE Kyoto (p.R43C) and ApoE ...
YIA5 RGS-1 Regulates Leukocyte Trafficking in Atherosclerosis and Aortic Aneurysm Formation through Chemokine Receptor Desensitisation
YIA5 RGS-1 Regulates Leukocyte Trafficking in Atherosclerosis and Aortic Aneurysm Formation through Chemokine Receptor Desensitisation
The regulation of macrophage recruitment and retention into the vascular wall is critical in the progression of atherosclerosis and aortic aneurysm formation. This can be mediated ...
Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice
Mononuclear cell therapy attenuates atherosclerosis in apoE KO mice
Abstract
Background
Recent studies have highlighted the potential of cell therapy for atherosclerosis. The aim of this study was to evaluate the ...
e0175 The effect of ghrelin on the regression of atherosclerosis plaque in ApoE-/- mice aorta
e0175 The effect of ghrelin on the regression of atherosclerosis plaque in ApoE-/- mice aorta
Objective
To observe the effect of ghrelin on reducing the apoE−/− mice plasma IL-8, MCP-1, TNFα level and the NFκBp65 expression in vascular wall and the regress...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Abstract 155: Contribution of Foamy Monocytes to Nascent Atherosclerosis
Abstract 155: Contribution of Foamy Monocytes to Nascent Atherosclerosis
Infiltration of monocytes into the arterial wall and subsequent differentiation into macrophages, which take up lipoproteins to become foam cells, is a key step in atherogenesis. W...
High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA‐I Dysfunctionality
High Serum Apolipoprotein E Determines Hypertriglyceridemic Dyslipidemias, Coronary Disease and ApoA‐I Dysfunctionality
AbstractThe relevance of serum apolipoprotein E (apoE) levels to two hypertriglyceridemic dyslipidemias has not been clarified. We explored, in a cross‐sectional (and short‐term pr...
APOE4 increases energy metabolism in APOE-isogenic iPSC-derived neurons
APOE4 increases energy metabolism in APOE-isogenic iPSC-derived neurons
AbstractThe apolipoprotein E4 (APOE4) allele represents the major genetic risk factor for Alzheimer’s disease (AD). In contrast, APOE2 is known to lower the AD risk while APOE3 is ...

